Graefes Arch Clin Exp Ophthalmol. 2022 Oct 21. doi: 10.1007/s00417-022-05849-6. Online ahead of print.
ABSTRACT
PURPOSE: To examine associations between the topographic distribution of geographic atrophy (GA) and vision-related quality of life (VRQoL).
METHODS: This study included 237 eyes from 161 participants in the Age-Related Eye Disease Study (AREDS). GA lesions were manually delineated with color fundus photographs obtained by the AREDS Research Group and atrophic area was measured in an Early Treatment Diabetic Retinopathy Study (ETDRS) grid. VRQoL was measured using the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Area of atrophy in the ETDRS grid subfields was correlated with VRQoL by linear regression modeling.
RESULTS: The average area of atrophy in the better and worse eye was 3.43mm2 and 7.15mm2 respectively. In multivariable analysis, VRQoL was not associated with total area of atrophy in the better eye (β, – 0.53; 95% confidence interval [CI], – 1.11 to 0.05; P = 0.07) or worse eye (β, 0.12; 95% CI, – 0.32 to 0.55; P = 0.59). However, area of atrophy in the central 1-mm-diameter zone of the better eye was significantly associated with VRQoL when the ETDRS subfields were examined individually (β, – 14.57; 95% CI, – 27.12 to – 2.02; P = 0.023), grouped into quadrants (β, – 18.35; 95% CI, – 30.03 to – 6.67; P = 0.002), inner and outer zones (β, – 17.26; 95% CI, – 29.38 to – 5.14; P = 0.006), or vertical and horizontal zones (β, – 18.97; 95% CI, – 30.18 to – 7.77; P = 0.001).
CONCLUSION: In patients with GA, greater area of atrophy in the central 1-mm-diameter zone of the better eye was independently associated with lower VRQoL, while total area of atrophy in the better or worse eye was not.
PMID:36269402 | DOI:10.1007/s00417-022-05849-6
